Management of Chronic Cervicitis by Oral administration of Tablet Triphala Guggulu and Yoni Pichu with Darvi Taila
- Conditions
- Health Condition 1: N72- Inflammatory disease of cervix uteri
- Registration Number
- CTRI/2024/03/064419
- Lead Sponsor
- Faculty of Ayurveda Institute of Medical Sciences BH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Only married women of different age group and parity.
2. Patients presenting with at least any 3 of the following clinical signs and symptomatology
of chronic Cervicitis like -
a. Patients presenting with mucopurulent discharge p/v and endocervical bleed.
b. Patients having inflammatory Cervical Pap smear.
c. Patients presenting with clinical features of dyspareunia and cervical tenderness.
d. Patients presenting with clinical features of cervical congestion /strawberry cervix.
e. Patients presenting with intermenstrual/ post coital bleeding.
f. Patients presenting with other symptoms of cervicitis like back ache and lower
abdominal pain.
1. Unmarried
2. Pregnant women and Patients suffering from any specific organic lesions such as
Tuberculosis, acute or chronic respiratory diseases, cardiac diseases, renal diseases,
Diabetes mellitus, Hypertension etc.
3. Women with carcinoma of cervix, benign or malignant growth of reproductive tract, any
degree of genital prolapses.
4. Patients having their HIV and VDRL reactive.
16
5. Patients with Cervical Pap smear showing either CIN or papilloma virus infection or
invasive malignancy.
6. Patients having Acute cervicitis.
7. Patients having Acute Pelvic inflammatory disease.
8. Patients with h/o surgery of cervix.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Based on Subjective and Objective criteria and Laboratory investigations <br/ ><br>Subjective criteria: <br/ ><br>? Vaginal discharge <br/ ><br>? Post coital bleeding <br/ ><br>? Back ache <br/ ><br>? Inter menstrual spotting <br/ ><br>? Dyspareunia <br/ ><br>Objective criteria: <br/ ><br>? Cervical Congestion <br/ ><br>? Cervical discharge <br/ ><br>? Vaginal discharge <br/ ><br>? Cervical tenderness <br/ ><br>? Contact bleeding <br/ ><br>Laboratory investigations <br/ ><br>? Positive inflammatory Pap smear <br/ ><br>? Positive endocervical swab culture <br/ ><br>? ColposcopyTimepoint: 3 Follow ups with equal interval of 15 days
- Secondary Outcome Measures
Name Time Method Reduced inflammation ,alleviated symptoms and improved quality of life among study participantsTimepoint: 3 follow ups with Regular interval of 15 days.2 follow ups with medication and 1 follow up without medication